Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancer

SUPPLEMENTARY MATERIALS
Supplementary Figure 1: Cell viability is reduced following treatment with AZD7328 and KU-0063794 in primary prostate cells. An MTS assay was performed with primary prostate cultures (derived from cancers, n=3 and from BPH, n=1) treated with increasing concentrations of AKT and mTOR inhibitors, for 72 hours. Cell viability was determined relative to the vehicle control (0.5% DMSO). The analysis was performed using GraphPad Prism 7.0 software. Error bars represent standard deviation of technical replicates. showed presence of a number of point mutations (highlighted in red boxes), resulting in missense mutations of the region encoding the phosphatase domain of the PTEN. The Polymerase chain reaction (PCR) was used to amplify matched lymphocyte and tumour DNA from the patient primary cultures to determine mutational status of the PTEN gene. Standard PCR conditions were adapted for the analysis of PTEN exon 5; PCR products were column purified using Qiagen Quick PCR clean up kit and then directly sequenced using PTEN exon 5 sequencing primers ( Table 2 ). The presence of mutations was determined by using EditSeq software (DNASTAR). (B) PTEN protein expression was determined in primary cultures using western blotting. Whole cell lysates were prepared and 20 µg of protein was loaded per lane onto a 10% SDS gel, electrotransferred onto PVDF membranes and immuno-stained for PTEN protein. Whole lysates from BPH1 (PTEN-positive cell line) and PC3 (PTEN-negative cell line) were used as controls. Staining with β-actin antibody was used as a loading control. The bands were quantified using Image J software and the expression normalized to BPH-1 (positive control); the values are shown below the blot. KU-0063794 alone or in a combination of 5 + 5 for 72 hours. Cells were subsequently collected, whole cell lysates prepared and quantified. 20 μg of protein was loaded per lane, electrotransferred to PVDF membrane and stained with antibodies against phospho-AKT (Ser473), phospho-ERK1/2 (T202/Tyr204) and phospho-S6 (Ser235/236). Staining with β-actin antibody was used as a loading control. The bands were quantified using Image J software and the expression levels normalized to the vehicle control; the values are shown below the blot.
